Decrease the Frequency of Inappropriate Intravenous Lines in Internal Medicine (PERMI)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Stephane Mouly, MD PhD, Hopital Lariboisière
ClinicalTrials.gov Identifier:
NCT01633307
First received: June 19, 2012
Last updated: July 3, 2012
Last verified: June 2012
  Purpose

Aim: to determine whether a nationwide teaching program delivered to medical doctors can decrease the use of inappropriate intravenous lines in internal medicine


Condition Intervention Phase
Acute Medical Patients Hospitalized in Internal Medicine
Other: Education
Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Official Title: Effect of a Nationwide Teaching Program on the Frequency of Inappropriate Intravenous Lines in Internal Medicine: A Randomized Controlled Trial

Further study details as provided by Hopital Lariboisière:

Primary Outcome Measures:
  • frequency of inappropriate intravenous infusion in internal medicine department [ Designated as safety issue: No ]

Enrollment: 59
Study Start Date: January 2007
Study Completion Date: May 2007
Primary Completion Date: April 2007 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Experimental
Intervention (Teaching program)
Other: Education
Teaching program
No Intervention: Control group
No teaching program

Detailed Description:

Nationwide multicentre randomized prospective controlled trial enrolling 59 french internal medicine departments. During the first study visit, we collected data of patients with intravenous infusions from each participating centre in order to determine the number and frequency of inappropriate intravenous lines. Using a computerized randomization process (on a 1:1 basis), the participating centres were randomized; Half centres (interventional group) received an educational program consisting of educational material and two educational sessions; the other half did not receive the educational program (control group). The educational program provided medical doctors with posters and slides containing information on valid indications for the prescription and use of intravenous infusions (inability to drink or eat, malabsorption, medication only available intravenously with no oral equivalent). Based on a previous pilot study, we assumed that the the frequency of inappropriate intravenous lines with be approximately 20% at baseline and hypothesize that the nationwide teaching program will decrease this frequency by 50%.

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Internal medicine department
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01633307

Sponsors and Collaborators
Hopital Lariboisière
Investigators
Principal Investigator: stephane J mouly, MD PhD Hopital Lariboisiere
  More Information

No publications provided by Hopital Lariboisière

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Stephane Mouly, MD PhD, Professor of Medicine, Hopital Lariboisière
ClinicalTrials.gov Identifier: NCT01633307     History of Changes
Other Study ID Numbers: PERMI
Study First Received: June 19, 2012
Last Updated: July 3, 2012
Health Authority: France: Ministry of Health

Keywords provided by Hopital Lariboisière:
education
intravenous infusion

ClinicalTrials.gov processed this record on October 30, 2014